Alexion Pharmaceuticals, Inc. entered a definitive purchase agreement to acquire Assets of early-stage rare disease gene therapy portfolio of Pfizer Inc. for $1 billion.
Centerview Partners LLC acted as financial advisor to Pfizer Inc. Mike Riella, Patrick Manchester, Jessica Milner, Gustavo Akkerman, and Sara Needles of Covington & Burling LLP acted as legal advisors to Alexion. Lowell Dashefsky, David Menchel, Laurie Abramowitz, Jennifer Perkins, Matthew Tabas and Niels Christian Ersbøll of Arnold & Porter acted as legal advisors to Pfizer.